Lv41
502 积分 2025-05-14 加入
Perioperative immune checkpoint inhibitors combined with chemotherapy versus chemotherapy for locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis of randomized controlled trials
3小时前
待确认
Role of Diet in Colorectal Cancer Incidence
1天前
待确认
Pathologic Complete Response and Survival in Rectal Cancer
15天前
已完结
Pathologic Complete Response and Survival in Rectal Cancer
17天前
已完结
The efficacy of targeted therapy and/or immunotherapy with or without chemotherapy in patients with Colorectal Cancer: A Network Meta-Analysis
1个月前
已完结
Targeted doublet therapy with encorafenib and cetuximab for BRAF V600E-mutant metastatic colorectal cancer: A systematic review and meta-analysis
1个月前
已完结
P-7 Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal cancer: Update on the first real-world study in Germany and Austria – BERING CRC
1个月前
已关闭
O18-6 Safety of encorafenib, binimetinib, plus cetuximab for Japanese patients with BRAF V600E metastatic colorectal cancer
1个月前
已完结
Effectiveness and safety of encorafenib-cetuximab in BRAFV600E metastatic colorectal cancer: Confidence study
1个月前
已关闭
625P Efficacy and safety of the combination of encorafenib and cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: An AGEO real-world multicentre study
1个月前
已关闭
皖公网安备34019202002308
